siPLK1-IONPs were conjugated with myristolated polyarginine peptide (MPAP), a type of membrane translocation peptide that facilitated the transfer into the cytoplasm, and tumor-selective peptide under the glycosylated MUC1-specific peptide (EPPT1) that enhanced the tumor-specific delivery. The gene discussed is MUC1; the disease is neoplasm.